Kinfo
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc.

MAZENASDAQHealthcare·US · USD
$26.43
-0.22 (-0.83%)
Prices as of October 2, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.47B USD
Enterprise value1.16B USD
Trailing P/E189.50
Forward P/E-8.39
PEG ratio-145.91
Price / sales74.02
Price / book3.26
Profitability
Gross margin0.00%
Operating margin-728.06%
Profit margin0.00%
Return on assets-21.79%
Return on equity-37.35%
Income (TTM)
Revenue20.00M USD
Gross profit20.00M USD
EBITDA-143.71M USD
Net income-133.59M USD
Diluted EPS-$2.44
Rev. growth (YoY)-100.00%
Balance sheet
Total cash411.09M USD
Total debt60.42M USD
Debt / equity13.34
Current ratio18.31
Book value / share$8.16
Cash flow (TTM)
Operating cash flow-106.54M USD
Levered free cash flow-63.63M USD
Shares & price
Shares outstanding55.50M
Float36.76M
Held by institutions106.84%
Beta0.00
50-day MA$27.06
200-day MA$33.12
52-week high$53.65
52-week low$21.95
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-11-0.70-0.76−8.57%2026-03-25-0.69-0.65+5.80%2025-11-06-0.69-0.66+4.35%2025-10-151.341.37+2.24%2025-08-12-1.15-0.77+33.04%
About Maze Therapeutics, Inc.

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule precision medicines for kidney, cardiovascular, and related metabolic diseases, including obesity. The company uses its human genetics-driven Compass platform to identify disease-linked genetic variants and translate those insights into targeted drug candidates. Its current pipeline includes oral programs aimed at genetically defined kidney disorders, reflecting a strategy centered on precision medicine and biologically validated pathways. Maze Therapeutics operates from South San Francisco, California, and is positioned within the broader biotechnology sector as a developer of novel therapies for patients with renal and metabolic conditions.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
Employees
141
Headquarters
South San Francisco, CA, United States

Frequently asked questions about Maze Therapeutics, Inc.